INS and Hypoglycemia: Consistent with this, dose-response studies have shown that higher insulin levels during hypoglycemia do not further reduce EGP (51–54), suggesting that a modest gain in hepatic insulin sensitivity in FAST would not be expected to account for a 60% reduction in EGP.